Association Between Low Dose Acetylsalicylic Acid (ASA) and Proton Pump Inhibitors and Risk of Acute Myocardial Infarction or Coronary Death
NCT01360047
Coronary Death, Nonfatal Myocardial Infarction
Madrid, Spain
View Trial DetailsNCT Number: NCT01360073
The purpose of this study is to estimate the risk of myocardial infarction (MI)/coronary death associated with use of monotherapy low dose ASA (single antiplatelet) as well as concomitant use of monotherapy low dose ASA and proton pump inhibitors (PPIs) in patients with serious coronary heart disease using two UK primary care databases.
Looking for future studies?
Notify Me50 year–84 year
All sexes
Observational
Research Site, Madrid, Spain
Number of Anticipated Subjects: In case-control analysis: 10.000-15.000 participants
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Up to eight years from entry into study cohort
AstraZeneca
Industry
Association Between Low Dose Acetylsalicylic Acid (ASA) and Proton Pump Inhibitors and Risk of Acute Myocardial Infarction or Coronary Heart Disease Death - Nested Case Control Analyses in a Cohort of Patients With Acute Serious Coronary Heart Disease
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01360047
Coronary Death, Nonfatal Myocardial Infarction
Madrid, Spain
View Trial DetailsNCT01859897
Brain Diseases, Cardiovascular Death
Okayama, Japan
View Trial DetailsNCT07212751
All-cause Death, Arterial Occlusive Diseases
Hong Kong
View Trial Details